These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 27070467)
1. [An open comparative observational study of the efficacy and safety of adaptol in anxiety-asthenic disorders in patients with chronic cerebral ischemia]. Vorob'eva OV; Repina VV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3):20-24. PubMed ID: 27070467 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacotherapy of anxiety disorders in patients with chronic cerebral ischemia]. Vorob'eva OV; Rusaya VV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12. Vyp. 2):49-55. PubMed ID: 28300804 [TBL] [Abstract][Full Text] [Related]
3. [Asthenic disorders in children and their differentiated treatment]. Chutko LS; Surushkina SI; Nikishena IS; Iakovenko EA; Anisimova TI; Bondarchuk IL; Sergeev AV Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):99-103. PubMed ID: 25726788 [TBL] [Abstract][Full Text] [Related]
4. [Clinical and neurophysiological study of the efficacy of adaptol in the treatment of emotional burn-out]. Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Rozhkova AV; Anisimova TI Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):30-3. PubMed ID: 21183911 [TBL] [Abstract][Full Text] [Related]
5. [The prognostic significance of brain-derived neurotrophic factor (BDNF) for phobic anxiety disorders, vegetative and cognitive impairments during conservative treatment including adaptol of some functional and organic diseases of nervous system]. Zhivolupov SA; Samartsev IN; Marchenko AA; Puliatkina OV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):37-41. PubMed ID: 22810739 [TBL] [Abstract][Full Text] [Related]
6. [Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options]. Zavadenko NN; Solomasova AA Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):44-8. PubMed ID: 23096041 [TBL] [Abstract][Full Text] [Related]
7. [Clinical-neurophysiological study of efficacy of adaptol in discirculatory encephalopathy]. Barantsevich ER; Posokhina OV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):68-72. PubMed ID: 22027612 [TBL] [Abstract][Full Text] [Related]
8. [Attention deficit syndrome in adults: clinical, psychophysiological features and treatment]. Chutko LS; Surushkina SIu; Iakovenko EA; Nikishena IS; Anisimova TI Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(8):38-41. PubMed ID: 24077549 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction]. Shilina NN; Statsenko ME; Sporova OE; Lempert BA Ter Arkh; 2013; 85(9):29-34. PubMed ID: 24261227 [TBL] [Abstract][Full Text] [Related]
10. [Asthenic disorders in children]. Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Anisimova TI; Kuzovenkova MP Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):26-9. PubMed ID: 21183919 [TBL] [Abstract][Full Text] [Related]
11. [Neurocirculatory asthenia: psychoautonomic features and treatment possibilities]. Frolova NL; Chutko LS; Surushkina SIu Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):51-4. PubMed ID: 23388593 [TBL] [Abstract][Full Text] [Related]
12. [Adaptol--verges of possible]. Mkrtchian VR; Kozhokova LZ Lik Sprava; 2012; (5):125-33. PubMed ID: 23534281 [TBL] [Abstract][Full Text] [Related]
13. [To study the effectiveness and impact on the quality of life of patients with subclinical and clinically pronounced anxiety disorder of a mobile application in combination with Adaptol therapy]. Levin OS Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(7):98-105. PubMed ID: 39113449 [TBL] [Abstract][Full Text] [Related]
14. [A case of effective psychogenic ventricular arrhythmia treatment with the anxiolytic Adaptol]. Tsurinova EA; Treshkur TV; Il'ina DIu Ter Arkh; 2013; 85(3):94-7. PubMed ID: 23720851 [TBL] [Abstract][Full Text] [Related]
15. [Psychoautonomic disorders in patients with hypertension, stage I and possibilities of their treatment]. Frolova NI; Chutko LS; Surushkina SY Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):43-7. PubMed ID: 24107879 [TBL] [Abstract][Full Text] [Related]
16. [Generalized anxiety disorder: psychosomatic aspects and treatment approaches]. Chutko LS; Rozhkova AV; Sidorenko VA; Surushkina SIu; Tursunova KB Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):40-4. PubMed ID: 22678674 [TBL] [Abstract][Full Text] [Related]
17. [A dyad approach to the treatment of attention deficit hyperactivity disorder]. Chutko LS; Surushkina SY; Anisimova TI Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):81-84. PubMed ID: 28374698 [TBL] [Abstract][Full Text] [Related]
18. [Adaptol in the treatment of anxiety disorders in children with school maladaptation]. Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Anisimova TI; Livinskaia AM; Sidorova IuI; Kuzovenkova MP; Aĭtbekov KA; Mamaeva IuV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(2):45-9. PubMed ID: 20436449 [TBL] [Abstract][Full Text] [Related]
19. Use of adaptol in the treatment of chronic fatigue syndrome in patients with chronic cerebral ischemia. Mokina TV; Antipenko EA; Gustov AV Neurosci Behav Physiol; 2010 Sep; 40(7):757-9. PubMed ID: 20635214 [No Abstract] [Full Text] [Related]
20. [Clinical efficiency of combined therapy using adaptol for atopic dermatitis]. Orlov EV; Konnov PE; Arsen'eva AA Ter Arkh; 2014; 86(5):78-82. PubMed ID: 25026806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]